Johnson & Johnson Cv Rx, Inc. Transaction History
Johnson & Johnson
- $314 Million
- Q3 2024
A detailed history of Johnson & Johnson transactions in Cv Rx, Inc. stock. As of the latest transaction made, Johnson & Johnson holds 4,103,430 shares of CVRX stock, worth $55.4 Million. This represents 11.52% of its overall portfolio holdings.
Number of Shares
4,103,430
Previous 4,103,430
-0.0%
Holding current value
$55.4 Million
Previous $49.2 Million
26.52%
% of portfolio
11.52%
Previous 16.99%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Nea Management Company, LLC Timonium, MD2.37MShares$32 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$11.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$11.1 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$9.22 Million0.85% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY545KShares$7.36 Million0.03% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $278M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...